Alemtuzumab + Rituximab Consolidation in CLL
Clinical trial NCT00771602 · TERMINATED
Trial details
- NCT number
- NCT00771602
- Sponsor
- M.D. Anderson Cancer Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-08-01
- Primary completion
- 2010-12-01
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.